Your institution may have access to this item. Find your institution then sign in to continue.
Title
Long-Term Results From a Randomized Phase II Trial of Standard- Versus Higher-Dose Imatinib Mesylate for Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing KIT
Authors
Blanke, Charles D.; Demetri, George D.; von Mehren, Margaret; Heinrich, Michael C.; Eisenberg, Burton; Fletcher, Jonathan A.; Corless, Christopher L.; Fletcher, Christopher D.M.; Roberts, Peter J.; Heinz, Daniela; Wehre, Elisabeth; Nikolova, Zariana; Joensuu, Heikki
Publication
Journal of Clinical Oncology, 2008, Vol 26, Issue 4, p620